US Stock MarketDetailed Quotes
LUCD Lucid Diagnostics
- 0.781
- -0.018-2.27%
Trading Apr 19 14:40 ET
37.67MMarket Cap-619P/E (TTM)
0.800High0.765Low100.57KVolume0.795Open0.799Pre Close78.75KTurnover0.67%Turnover RatioLossP/E (Static)48.24MShares1.85052wk High-1.80P/B11.77MFloat Cap0.76452wk Low--Dividend TTM15.07MShs Float13.520Historical High--Div YieldTTM4.37%Amplitude0.764Historical Low0.782Avg Price1Lot Size
About Lucid Diagnostics Company
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Company Profile
SymbolLUCD
Company NameLucid Diagnostics
Listing DateOct 14, 2021
Issue Price14.00
Founded2018
CEODr. Lishan Aklog, M.D.
MarketNASDAQ
Employees70
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address360 Madison Avenue,25th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-212-949-4319
Websitehttp://www.luciddx.com
Company Executives
- Name
- Position
- Salary
- Dr. Lishan Aklog, M.D.
- Chief Executive Officer and Chairman of the Board
- 455.70K
- Shaun O'Neil
- President, Chief Operating Officer and Executive Vice President.
- 665.40K
- Dennis M. McGrath, C.P.A.
- Principal Accounting Officer, Chief Financial Officer and Corporate Secretary
- 394.20K
- Stanley N. Lapidus
- Vice Chairman of the Board
- 207.64K
- Dr. James L. Cox, M.D.
- Independent Director
- 220.64K
- Ronald M. Sparks, Jr
- Independent Director
- 242.64K
- Dr. Jacque J. Sokolov,M.D.
- Independent Director
- 245.14K
- Debra J. White
- Independent Director
- 189.74K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg